Category:
Fine Chemicals
CAS NO:
n\a
Standard:
In-house Standards,

Dasatinib Tablets
[Dosage form]
Tablet
[Indication]
Indicated for the treatment of adults with
1.newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase
2.chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib
3.Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy
[Specification]
20mg, 50mg
[Originator]
Sprycel ® from Bristol Myers Squibb